Mammary tissue architecture |
P53 |
SREBP-1 and SREBP-2 |
Disruption of normal acinar morphology via mutant p53 |
MDA-468, MDA-231, and MCF10A |
rBM matrix |
[79] |
|
NF-κB |
Disorganization genes |
Disruption of tissue polarity and organization |
HMT-3522 S1 and T4-2 cells |
rBM matrix |
[83] |
|
GATA3 |
|
Induces proliferation via mutant GATA3s |
ZR751 |
Xenograft |
[87] |
|
TAZ |
IRS1 |
Induces proliferation |
MCF10A |
rBM matrix |
[90] |
|
SOX7 |
|
SOX7 depletion causes loss of polarity and increased proliferation |
MCF10A |
rBM matrix |
[93] |
|
TBX3 |
|
Branching morphology |
MDA-MB-231 |
rBM matrix |
[198] |
|
MRTF-A and MRTF-B |
integrin α5, integrin α6 |
Disruption of normal acinar morphology |
MCF10A |
rBM matrix |
[96] |
|
Sp1 |
|
Stiffness-induced tumorigenic phenotype and chromatin organization |
MCF7 and MDA-MB-231 |
rBM matrix |
[100] |
EMT and metastasis |
TWIST1 |
ADAM12 |
Induces tumor invasion and metastasis |
Hs578T and HMLE cells |
Matrigel–collagen mixture |
[113] |
|
TWIST1 |
PRKD1 |
Promotes invasion, epithelial dissemination, and metastasis |
murine and human mammary tumor tissues |
Organoid |
[116] |
|
SNAIL |
|
SNAIL inhibition reduces invasion and metastasis |
MCF7 |
|
[120] |
|
SNAIL |
|
Downregulation of Snail induces a reversal of EMT in the bone |
MDA-MB-231, mammary tumor cells, osteoblast-like cells |
rBM matrix |
[139] |
|
STAT3 |
LINC00520 |
Invasion and metastasis |
MCF10A-Src transformed cells |
rBM matrix, bioprinting |
[121] |
|
STAT3 |
|
STAT3 inhibition blocks invasion |
primary tumor tissue explant culture |
rBM matrix |
[122] |
|
∆Np63α |
|
∆Np63α inhibition induces EMT |
MCF10A |
3D collagen gel |
[126] |
|
OCT1-SOX2, PAX6-SOX2, OCT4-SOX2 |
|
aggressive cancer phenotype |
T47D |
|
[130] |
|
SP1, ZNF281, ZNF740, MZF1 and RREB1 |
|
aggressive cancer phenotype |
T47D |
|
[130] |
|
ZEB1 |
E- and N-cadherins |
Induces EMT |
HT1080 |
rBM matrix |
[135] |
|
PROX1 |
MMP14 |
Inhibits invasion |
MDA-MB-231 |
3D fibrin matrix |
[127] |
|
JunB |
|
EMT-induction |
NMuMG and iLEC cells |
3D co-culture fibrin beads |
[140] |
Apoptosis |
NF-κB |
|
Induced by tissue polarity and drives resistance to apoptosis |
HMT-3522 sourced S-1 and T4-2 cells |
rBM matrix |
[56] |
|
RUNX2 |
Bcl-2 and IL-8 |
Disruption of normal acinar morphology, increased cell proliferation |
MCF10A and MDA-MB-231 |
rBM matrix |
[91] |
|
IRF6 |
|
Induced by detachment and downregulation causes anoikis resistance |
MCF10A, HMEC |
rBM matrix |
[153] |
Therapy resistance and drug response |
HIF-1α |
MDR-1 |
Increased resistance to doxorubicin |
MCF7 |
|
[173] |
|
NF-κB |
β1-integrin |
Increased radioresistance |
HMT-3522 S1 and T4-2 cells |
rBM matrix |
[176] |
|
MYC |
|
Drives resistance to everolimus |
MCF7, ZR75, CAMA-1 |
rBM matrix |
[180] |
|
E2F1, ELK1, GATA, P53 and STAT4 |
|
Increased activity upon lapatinib treatment |
MCF10A/ErbBB2 |
rBM matrix |
[188] |
|
SREBP2 |
HMGCR and HMGCS1 |
Sensitizes to fluvastatin-induced apoptosis |
MDA-MB-231 and MCF7 |
rBM matrix |
[187] |
Stemness |
SOX2 and FOXO1 |
|
Accumulation of FOXO1 and enhanced SOX2 transcription supports BC stemness |
Human breast cancer tissues |
ULA plates |
[193] |
|
NANOG and OCT4 |
|
Increased expression in mammospheres |
MCF7 and SKBR3, and MDA-MB-231 |
Agar-coated plates |
[199] |
|
SOX2, NANOG, OCT4, and FOXO3 |
|
Increased expression in cell surface-GPNMBhigh cells |
BT-474, Hs578T, and MDA-MB-468 |
ULA or HEMA-coated plates |
[201] |